US chemical makers push for faster EPA reviews to revive domestic production, ETChemicals
The Breakdown
US specialty chemical manufacturers are sounding the alarm on the pace and predictability of new chemical reviews by the EPA—a process they believe is now a critical bottleneck for domestic production, supply chain resilience, and global competitiveness. As Congress considers reauthorizing EPA’s fee authority under the Toxic Substances Control Act (TSCA) by September 2026, industry leaders are calling for reform that aligns regulatory timelines with commercial realities. Survey data reveals significant project delays, lost investments, and location decisions shifting away from the US due to uncertainty and sluggish regulatory cycles. With policy and industrial capacity at stake, the debate over Section 5 review timelines has escalated beyond compliance, becoming a strategic inflection point for the future of American chemical innovation and manufacturing.
Analyst View
Leaders across the specialty chemical and advanced materials sectors are being forced to reassess both their US investment thesis and global production deployment as regulatory processes become slower and less predictable. Prolonged EPA review times—now exceeding a year for many new chemistry applications—are not only postponing new product introductions but causing 82% of surveyed firms to lose business opportunities and 70% to abandon projects entirely. Such delays reverberate through internal planning cycles and jeopardize the ability to synchronize launches with downstream customer requirements or to secure capital for expansion.
This uncertainty is shifting manufacturing decisions: two-thirds of industry respondents have reconsidered US facility expansions, and nearly all believe improved regulatory predictability would accelerate reshoring. Critically, the issue extends beyond established core products; delays are stalling innovation in growth-critical segments such as PFAS alternatives, materials for semiconductors, and pharmaceutical precursors—segments directly tied to national industrial priorities. For mid-sized manufacturers with limited financial flexibility, regulatory unpredictability can kill projects before they reach commercial scale.
The risk calculus is changing. Where and how companies invest now hinges not just on demand signals or market need, but on the real and perceived risks embedded in the regulatory approval pathway—a factor increasingly influential in growth strategies and competitive positioning.
Navigating the Signals
Decision makers should recognize that differentiation today depends as much on regulatory navigation as on technical capability or channel access. When new product launches and plant investments become hostage to unpredictable timelines, strategic agility and supply chain confidence suffer. The current debate around TSCA Section 5 is thus a barometer for operational resilience, with implications for where innovation and advanced manufacturing are realized over the next decade.
Companies should ask: Are our market entry plans robust against regulatory drift? How are approval uncertainties being factored into our capital allocation and customer commitments? What is the impact of these delays on our ability to partner, finance, and compete in fast-moving segments? Furthermore, leadership teams must look beyond compliance, continually benchmarking not only their internal regulatory readiness but also their supply chain’s ability to adapt to evolving approval cycles.
What’s Next?
Breakthrough Marketing Technology helps specialty chemical leaders navigate regulatory headwinds and drive growth decisions by turning market signals into forward-looking strategies. Our expertise provides clarity amid complexity, supporting teams to:
- Quantify the commercial impact of regulatory uncertainty on portfolio decisions, customer engagement, and capital deployment.
- Identify and prioritize product segments and innovation programs most at-risk under current review timelines.
- Benchmark global market entry options, highlighting competitive alternatives and location risks.
- Catalyze executive alignment on investment timing, channel readiness, and partnership models under uncertainty.
Our structured approach empowers your organization to seize opportunity—regardless of volatility in the operating environment.
Source
Understand Your Risk. Seize Your Opportunity.
Take the Breakthrough Market Uncertainty Assessment Guide to pinpoint what’s holding your growth back, and what can accelerate it.
